Steven Douglas Rauch, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meniere Disease | 29 | 2024 | 163 | 7.880 |
Why?
|
Vestibular Evoked Myogenic Potentials | 14 | 2021 | 88 | 5.430 |
Why?
|
Hearing Loss, Sensorineural | 31 | 2024 | 781 | 4.350 |
Why?
|
Hearing Loss, Sudden | 11 | 2024 | 45 | 3.610 |
Why?
|
Labyrinth Diseases | 8 | 2019 | 151 | 2.660 |
Why?
|
Vertigo | 11 | 2021 | 202 | 2.520 |
Why?
|
Vestibular Function Tests | 12 | 2021 | 128 | 2.290 |
Why?
|
Dizziness | 8 | 2021 | 257 | 2.160 |
Why?
|
Endolymphatic Sac | 6 | 2024 | 49 | 1.850 |
Why?
|
Vestibule, Labyrinth | 10 | 2019 | 232 | 1.810 |
Why?
|
Audiometry, Pure-Tone | 11 | 2019 | 210 | 1.620 |
Why?
|
Vestibular Nerve | 9 | 2019 | 101 | 1.560 |
Why?
|
Otolaryngology | 9 | 2020 | 685 | 1.440 |
Why?
|
Speech Perception | 9 | 2021 | 505 | 1.350 |
Why?
|
Saccule and Utricle | 7 | 2019 | 81 | 1.150 |
Why?
|
Semicircular Canals | 7 | 2021 | 203 | 1.080 |
Why?
|
Ear, Inner | 12 | 2024 | 424 | 1.040 |
Why?
|
Migraine Disorders | 7 | 2021 | 1694 | 0.930 |
Why?
|
Auditory Threshold | 9 | 2019 | 369 | 0.870 |
Why?
|
Gentamicins | 4 | 2020 | 251 | 0.870 |
Why?
|
Hearing Aids | 4 | 2011 | 58 | 0.850 |
Why?
|
Evoked Potentials, Auditory | 5 | 2006 | 529 | 0.830 |
Why?
|
Temporal Bone | 14 | 2024 | 683 | 0.820 |
Why?
|
Audiometry | 12 | 2019 | 253 | 0.800 |
Why?
|
Acoustic Stimulation | 8 | 2019 | 1232 | 0.750 |
Why?
|
Hearing | 5 | 2021 | 501 | 0.740 |
Why?
|
Syncope | 3 | 2017 | 427 | 0.710 |
Why?
|
Adrenal Cortex Hormones | 6 | 2014 | 1870 | 0.710 |
Why?
|
Hearing Loss | 3 | 2019 | 780 | 0.690 |
Why?
|
Cochlear Implantation | 3 | 2021 | 315 | 0.680 |
Why?
|
Otologic Surgical Procedures | 1 | 2020 | 149 | 0.660 |
Why?
|
Cochlea | 4 | 2017 | 844 | 0.650 |
Why?
|
Vestibular Diseases | 6 | 2021 | 229 | 0.640 |
Why?
|
Prednisone | 7 | 2012 | 1565 | 0.590 |
Why?
|
Neck Muscles | 5 | 2019 | 100 | 0.550 |
Why?
|
Cochlear Implants | 1 | 2021 | 338 | 0.550 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2017 | 144 | 0.510 |
Why?
|
Audiometry, Speech | 3 | 2011 | 11 | 0.500 |
Why?
|
Electromyography | 7 | 2019 | 1388 | 0.480 |
Why?
|
Glucocorticoids | 5 | 2018 | 2144 | 0.460 |
Why?
|
Methylprednisolone | 2 | 2012 | 384 | 0.430 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 298 | 0.420 |
Why?
|
Speech Discrimination Tests | 4 | 2009 | 35 | 0.410 |
Why?
|
Tympanic Membrane | 6 | 2018 | 232 | 0.410 |
Why?
|
Sensation Disorders | 2 | 2011 | 160 | 0.370 |
Why?
|
HSP70 Heat-Shock Proteins | 5 | 2000 | 397 | 0.350 |
Why?
|
Autoimmune Diseases | 5 | 2014 | 2244 | 0.350 |
Why?
|
Hearing Loss, Bilateral | 3 | 2009 | 53 | 0.340 |
Why?
|
Pharmaceutical Preparations | 1 | 2018 | 1090 | 0.340 |
Why?
|
Endolymphatic Hydrops | 3 | 2018 | 30 | 0.320 |
Why?
|
Humans | 107 | 2024 | 758381 | 0.310 |
Why?
|
Perilymph | 2 | 2000 | 49 | 0.300 |
Why?
|
Prednisolone | 1 | 2009 | 326 | 0.300 |
Why?
|
Ear Neoplasms | 2 | 2018 | 118 | 0.290 |
Why?
|
Administration, Topical | 6 | 2018 | 697 | 0.280 |
Why?
|
Retrospective Studies | 27 | 2024 | 80170 | 0.280 |
Why?
|
Administration, Oral | 8 | 2018 | 3993 | 0.280 |
Why?
|
Comparative Effectiveness Research | 1 | 2012 | 715 | 0.270 |
Why?
|
Middle Aged | 54 | 2024 | 219560 | 0.270 |
Why?
|
Research Design | 4 | 2018 | 6154 | 0.270 |
Why?
|
Adult | 55 | 2024 | 219916 | 0.260 |
Why?
|
Hair Cells, Vestibular | 3 | 2000 | 48 | 0.260 |
Why?
|
Ear, Middle | 3 | 2014 | 338 | 0.250 |
Why?
|
Aged | 43 | 2024 | 168217 | 0.240 |
Why?
|
Injections | 3 | 2014 | 830 | 0.230 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7985 | 0.230 |
Why?
|
Algorithms | 3 | 2021 | 13959 | 0.230 |
Why?
|
Hearing Disorders | 2 | 2003 | 126 | 0.230 |
Why?
|
Biomedical Research | 2 | 2017 | 3417 | 0.230 |
Why?
|
Tinnitus | 3 | 2019 | 194 | 0.220 |
Why?
|
Male | 59 | 2024 | 358742 | 0.220 |
Why?
|
Neural Inhibition | 2 | 2019 | 589 | 0.220 |
Why?
|
Anti-Inflammatory Agents | 2 | 2012 | 1793 | 0.220 |
Why?
|
ROC Curve | 3 | 2019 | 3563 | 0.210 |
Why?
|
Female | 59 | 2024 | 390316 | 0.210 |
Why?
|
Reference Values | 5 | 2019 | 4919 | 0.210 |
Why?
|
Ear Diseases | 2 | 2003 | 177 | 0.210 |
Why?
|
Vestibular Aqueduct | 2 | 2024 | 73 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3018 | 0.210 |
Why?
|
Medical Records Systems, Computerized | 1 | 2009 | 1190 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.210 |
Why?
|
Stapes Surgery | 3 | 2006 | 60 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.200 |
Why?
|
Prospective Studies | 14 | 2021 | 54136 | 0.200 |
Why?
|
Muscle Contraction | 2 | 2018 | 1196 | 0.190 |
Why?
|
Evoked Potentials, Motor | 1 | 2004 | 461 | 0.190 |
Why?
|
Dexamethasone | 1 | 2009 | 1927 | 0.190 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 4 | 2013 | 253 | 0.180 |
Why?
|
Hair Cells, Auditory | 2 | 2001 | 379 | 0.180 |
Why?
|
Sensitivity and Specificity | 8 | 2024 | 14641 | 0.180 |
Why?
|
Aminoglycosides | 1 | 2001 | 163 | 0.170 |
Why?
|
Facial Nerve Diseases | 1 | 2000 | 49 | 0.170 |
Why?
|
Treatment Outcome | 17 | 2021 | 64379 | 0.170 |
Why?
|
Hyperacusis | 1 | 2019 | 31 | 0.160 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2000 | 356 | 0.160 |
Why?
|
Transferrin | 1 | 2000 | 284 | 0.160 |
Why?
|
Physical Examination | 2 | 2021 | 1244 | 0.160 |
Why?
|
Sound Spectrography | 1 | 2019 | 113 | 0.160 |
Why?
|
Functional Laterality | 2 | 2006 | 2252 | 0.160 |
Why?
|
Noise, Occupational | 1 | 2017 | 26 | 0.150 |
Why?
|
Postural Balance | 5 | 2013 | 617 | 0.150 |
Why?
|
Ion Transport | 1 | 2018 | 318 | 0.150 |
Why?
|
Medical History Taking | 1 | 2021 | 772 | 0.150 |
Why?
|
Fistula | 2 | 2000 | 214 | 0.140 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 225 | 0.140 |
Why?
|
Electronystagmography | 3 | 2001 | 25 | 0.140 |
Why?
|
Meningitis | 1 | 1997 | 218 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 10146 | 0.130 |
Why?
|
Speech Reception Threshold Test | 2 | 2006 | 16 | 0.120 |
Why?
|
Genes, mos | 2 | 1992 | 3 | 0.120 |
Why?
|
Bone Conduction | 3 | 2013 | 102 | 0.120 |
Why?
|
Triage | 1 | 2021 | 986 | 0.120 |
Why?
|
Steroids | 2 | 2012 | 926 | 0.120 |
Why?
|
Craniocerebral Trauma | 1 | 2018 | 491 | 0.110 |
Why?
|
Deafness | 1 | 1997 | 457 | 0.110 |
Why?
|
Reflex | 1 | 2015 | 376 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 832 | 0.110 |
Why?
|
Vestibulocochlear Nerve Diseases | 1 | 2013 | 33 | 0.110 |
Why?
|
Fenestration, Labyrinth | 1 | 1992 | 3 | 0.110 |
Why?
|
Sodium | 1 | 2018 | 1588 | 0.110 |
Why?
|
Argon | 1 | 1992 | 36 | 0.110 |
Why?
|
Cerebellopontine Angle | 1 | 1993 | 53 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20500 | 0.100 |
Why?
|
Hearing Tests | 1 | 2013 | 121 | 0.100 |
Why?
|
Ossicular Prosthesis | 3 | 2006 | 36 | 0.100 |
Why?
|
Disease Progression | 3 | 2019 | 13468 | 0.100 |
Why?
|
Hemangioma | 1 | 1997 | 727 | 0.100 |
Why?
|
Cell Count | 5 | 2013 | 1835 | 0.100 |
Why?
|
Prognosis | 3 | 2024 | 29558 | 0.100 |
Why?
|
Antigens | 2 | 2000 | 1445 | 0.100 |
Why?
|
Aged, 80 and over | 12 | 2019 | 58681 | 0.100 |
Why?
|
Aging | 5 | 2019 | 8651 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1825 | 0.100 |
Why?
|
Jugular Veins | 1 | 1993 | 210 | 0.100 |
Why?
|
Hearing Loss, Conductive | 3 | 2004 | 159 | 0.100 |
Why?
|
Trigeminal Nuclei | 1 | 2011 | 39 | 0.090 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2011 | 42 | 0.090 |
Why?
|
Anti-Bacterial Agents | 4 | 2017 | 7403 | 0.090 |
Why?
|
Posterior Horn Cells | 1 | 2011 | 90 | 0.090 |
Why?
|
Motor Neurons | 1 | 2015 | 864 | 0.090 |
Why?
|
Stapes | 2 | 2008 | 89 | 0.090 |
Why?
|
Philosophy, Medical | 1 | 2010 | 79 | 0.090 |
Why?
|
Fractures, Bone | 2 | 2019 | 2040 | 0.090 |
Why?
|
Autoantibodies | 2 | 1995 | 2118 | 0.090 |
Why?
|
Trigeminal Ganglion | 1 | 2011 | 190 | 0.090 |
Why?
|
Afferent Pathways | 1 | 2011 | 298 | 0.080 |
Why?
|
Young Adult | 10 | 2024 | 58808 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2011 | 4839 | 0.080 |
Why?
|
Prostheses and Implants | 2 | 2002 | 1270 | 0.080 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 226 | 0.080 |
Why?
|
Meninges | 1 | 2011 | 197 | 0.080 |
Why?
|
Adolescent | 12 | 2018 | 87888 | 0.080 |
Why?
|
Neuroma, Acoustic | 1 | 1993 | 459 | 0.080 |
Why?
|
Diet, Sodium-Restricted | 1 | 2010 | 291 | 0.080 |
Why?
|
Intracranial Pressure | 1 | 2011 | 325 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2011 | 3671 | 0.080 |
Why?
|
Lasers | 1 | 1992 | 952 | 0.080 |
Why?
|
Salivary Gland Diseases | 1 | 1987 | 37 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1397 | 0.070 |
Why?
|
Diuretics | 1 | 2010 | 610 | 0.070 |
Why?
|
Auditory Pathways | 1 | 2009 | 237 | 0.070 |
Why?
|
Cortical Spreading Depression | 1 | 2011 | 288 | 0.070 |
Why?
|
Nociceptors | 1 | 2011 | 457 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2017 | 1809 | 0.070 |
Why?
|
Parotid Gland | 1 | 1987 | 175 | 0.070 |
Why?
|
Pain Threshold | 1 | 2011 | 603 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2012 | 1705 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15225 | 0.070 |
Why?
|
Vasodilation | 1 | 2011 | 960 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2211 | 0.070 |
Why?
|
Video Recording | 1 | 1992 | 954 | 0.070 |
Why?
|
Hyperalgesia | 1 | 2011 | 530 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2018 | 6233 | 0.070 |
Why?
|
Laryngoscopy | 1 | 1992 | 705 | 0.070 |
Why?
|
Ion Channels | 1 | 2011 | 1043 | 0.070 |
Why?
|
Caffeine | 1 | 2010 | 701 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 1993 | 1184 | 0.060 |
Why?
|
Congresses as Topic | 1 | 2011 | 799 | 0.060 |
Why?
|
Sample Size | 1 | 2009 | 838 | 0.060 |
Why?
|
Spiral Ganglion | 2 | 2000 | 177 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2018 | 12951 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 7377 | 0.060 |
Why?
|
Bulimia | 1 | 1987 | 400 | 0.060 |
Why?
|
Sensory Thresholds | 1 | 2006 | 377 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36285 | 0.060 |
Why?
|
Dictyostelium | 1 | 2005 | 70 | 0.060 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2005 | 102 | 0.060 |
Why?
|
Cohort Studies | 5 | 2014 | 41252 | 0.060 |
Why?
|
Neurons, Afferent | 1 | 2006 | 498 | 0.060 |
Why?
|
Facial Muscles | 1 | 1985 | 159 | 0.060 |
Why?
|
Analgesics | 1 | 2011 | 1064 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 6955 | 0.060 |
Why?
|
Orbital Fractures | 1 | 1985 | 109 | 0.060 |
Why?
|
Skull Fractures | 1 | 1985 | 202 | 0.050 |
Why?
|
Blotting, Western | 4 | 2000 | 5031 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6741 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2690 | 0.050 |
Why?
|
Autopsy | 2 | 2019 | 1003 | 0.050 |
Why?
|
Animals | 15 | 2021 | 167777 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 1992 | 9518 | 0.050 |
Why?
|
Documentation | 1 | 2009 | 892 | 0.050 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 1176 | 0.050 |
Why?
|
Nystagmus, Physiologic | 1 | 2001 | 29 | 0.050 |
Why?
|
Speech Intelligibility | 1 | 2021 | 79 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2270 | 0.050 |
Why?
|
Probability | 1 | 2006 | 2467 | 0.050 |
Why?
|
Acute Disease | 1 | 2011 | 7225 | 0.040 |
Why?
|
Biomedical Engineering | 1 | 2002 | 289 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 1991 | 1647 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2009 | 6293 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2009 | 12262 | 0.040 |
Why?
|
Guinea Pigs | 1 | 2021 | 1317 | 0.040 |
Why?
|
Decision Making | 2 | 2011 | 3915 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1593 | 0.040 |
Why?
|
United States | 3 | 2021 | 72140 | 0.040 |
Why?
|
Rotation | 1 | 2001 | 514 | 0.040 |
Why?
|
Nerve Net | 1 | 2011 | 2263 | 0.040 |
Why?
|
Membrane Proteins | 1 | 1995 | 7843 | 0.040 |
Why?
|
Wounds, Nonpenetrating | 1 | 1985 | 793 | 0.040 |
Why?
|
Immunodominant Epitopes | 1 | 1999 | 240 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2003 | 4158 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18125 | 0.040 |
Why?
|
Otitis Media, Suppurative | 1 | 1997 | 27 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2010 | 4020 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2018 | 290 | 0.040 |
Why?
|
Child, Preschool | 5 | 2001 | 42058 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2006 | 22031 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2001 | 12096 | 0.040 |
Why?
|
Sampling Studies | 1 | 2018 | 614 | 0.040 |
Why?
|
Mastoid | 1 | 1997 | 98 | 0.040 |
Why?
|
Methotrexate | 1 | 2003 | 1719 | 0.030 |
Why?
|
Cattle | 4 | 1999 | 3846 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2006 | 15785 | 0.030 |
Why?
|
Posture | 1 | 2001 | 953 | 0.030 |
Why?
|
Tissue Extracts | 2 | 1995 | 140 | 0.030 |
Why?
|
Child | 8 | 2001 | 79813 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2001 | 706 | 0.030 |
Why?
|
Pain | 1 | 2011 | 5065 | 0.030 |
Why?
|
Ossification, Heterotopic | 1 | 1997 | 235 | 0.030 |
Why?
|
Otosclerosis | 2 | 1994 | 113 | 0.030 |
Why?
|
Communication | 1 | 2009 | 3846 | 0.030 |
Why?
|
Rats | 1 | 2011 | 23681 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2000 | 3069 | 0.030 |
Why?
|
Parotitis | 1 | 1994 | 28 | 0.030 |
Why?
|
Neuroepithelial Cells | 1 | 2013 | 23 | 0.030 |
Why?
|
Specimen Handling | 1 | 2018 | 707 | 0.030 |
Why?
|
Observer Variation | 1 | 2000 | 2600 | 0.030 |
Why?
|
Patient Participation | 1 | 2003 | 1436 | 0.030 |
Why?
|
Tetracycline | 1 | 1994 | 219 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1630 | 0.030 |
Why?
|
Community Health Services | 1 | 2018 | 655 | 0.030 |
Why?
|
Isotopes | 1 | 1992 | 125 | 0.030 |
Why?
|
Head Movements | 1 | 2013 | 152 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 1 | 1993 | 135 | 0.030 |
Why?
|
Organ of Corti | 1 | 1992 | 85 | 0.030 |
Why?
|
Fetus | 1 | 2019 | 1860 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 1992 | 320 | 0.020 |
Why?
|
Prosthesis Design | 2 | 2006 | 2105 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10719 | 0.020 |
Why?
|
Stereotyped Behavior | 1 | 1991 | 135 | 0.020 |
Why?
|
Endolymph | 1 | 1989 | 20 | 0.020 |
Why?
|
Registries | 2 | 2018 | 8176 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2000 | 26182 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3356 | 0.020 |
Why?
|
Logistic Models | 2 | 2015 | 13276 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1628 | 0.020 |
Why?
|
Ear | 1 | 1990 | 172 | 0.020 |
Why?
|
Risk Assessment | 2 | 2018 | 23883 | 0.020 |
Why?
|
Infant | 3 | 2000 | 36054 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25953 | 0.020 |
Why?
|
Selection Bias | 1 | 2011 | 357 | 0.020 |
Why?
|
Sex Factors | 1 | 2003 | 10505 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2011 | 346 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 1993 | 653 | 0.020 |
Why?
|
Laryngeal Diseases | 1 | 1992 | 243 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1829 | 0.020 |
Why?
|
Voice Disorders | 1 | 1992 | 286 | 0.020 |
Why?
|
Models, Organizational | 1 | 2011 | 546 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2751 | 0.020 |
Why?
|
Age Factors | 2 | 2003 | 18357 | 0.020 |
Why?
|
Parotid Diseases | 1 | 1987 | 49 | 0.020 |
Why?
|
Medical Records | 1 | 2013 | 1406 | 0.020 |
Why?
|
Mucocele | 1 | 1987 | 51 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3262 | 0.020 |
Why?
|
Brain Stem | 1 | 1992 | 857 | 0.020 |
Why?
|
Malleus | 1 | 2006 | 27 | 0.020 |
Why?
|
Reoperation | 3 | 2006 | 4282 | 0.020 |
Why?
|
Antibodies | 1 | 1994 | 2420 | 0.020 |
Why?
|
Maxillary Sinus | 1 | 1987 | 180 | 0.020 |
Why?
|
Edema | 1 | 1989 | 768 | 0.020 |
Why?
|
Program Development | 1 | 2011 | 1297 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11070 | 0.020 |
Why?
|
Cerebellum | 1 | 1992 | 1497 | 0.020 |
Why?
|
Endoscopy | 1 | 1995 | 1834 | 0.010 |
Why?
|
Cadaver | 1 | 2008 | 1345 | 0.010 |
Why?
|
Equipment Design | 1 | 1992 | 3507 | 0.010 |
Why?
|
Species Specificity | 1 | 2008 | 2417 | 0.010 |
Why?
|
Reflex, Acoustic | 1 | 2004 | 34 | 0.010 |
Why?
|
Acoustic Impedance Tests | 1 | 2004 | 110 | 0.010 |
Why?
|
Health Services Research | 1 | 2011 | 1812 | 0.010 |
Why?
|
Diplopia | 1 | 1985 | 215 | 0.010 |
Why?
|
Mice | 3 | 2018 | 81107 | 0.010 |
Why?
|
Molecular Weight | 2 | 1995 | 2185 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2006 | 39060 | 0.010 |
Why?
|
Data Collection | 1 | 2011 | 3322 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6201 | 0.010 |
Why?
|
Eye Diseases | 1 | 1987 | 651 | 0.010 |
Why?
|
Chemotaxis | 1 | 2005 | 598 | 0.010 |
Why?
|
Mutagenesis | 1 | 2005 | 1233 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1992 | 2768 | 0.010 |
Why?
|
Streptomycin | 1 | 2000 | 70 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2009 | 1368 | 0.010 |
Why?
|
Kanamycin | 1 | 2000 | 64 | 0.010 |
Why?
|
Neomycin | 1 | 2000 | 93 | 0.010 |
Why?
|
Recurrence | 3 | 1997 | 8426 | 0.010 |
Why?
|
Proteins | 1 | 1994 | 6026 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1997 | 9273 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1999 | 346 | 0.010 |
Why?
|
Weight Gain | 1 | 2009 | 2346 | 0.010 |
Why?
|
Psychotherapy | 1 | 1987 | 1640 | 0.010 |
Why?
|
Motion Perception | 1 | 2002 | 372 | 0.010 |
Why?
|
Oval Window, Ear | 1 | 1997 | 21 | 0.010 |
Why?
|
Incus | 1 | 1997 | 19 | 0.010 |
Why?
|
Granulation Tissue | 1 | 1997 | 92 | 0.010 |
Why?
|
Ear Ossicles | 1 | 1997 | 71 | 0.010 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 1997 | 50 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29742 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1999 | 1060 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3867 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2002 | 1732 | 0.010 |
Why?
|
Ear Canal | 1 | 1997 | 146 | 0.010 |
Why?
|
Collodion | 1 | 1995 | 33 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1999 | 1991 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1995 | 297 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1995 | 645 | 0.010 |
Why?
|
Sialography | 1 | 1994 | 6 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 5410 | 0.010 |
Why?
|
Photomicrography | 1 | 1994 | 71 | 0.010 |
Why?
|
CD-ROM | 1 | 1993 | 24 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1994 | 322 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 1743 | 0.010 |
Why?
|
Antibodies, Antinuclear | 1 | 1994 | 344 | 0.010 |
Why?
|
Salivary Glands | 1 | 1994 | 229 | 0.010 |
Why?
|
Tissue Banks | 1 | 1993 | 184 | 0.010 |
Why?
|
Immunoblotting | 1 | 1995 | 1647 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 1997 | 1198 | 0.010 |
Why?
|
Skin Transplantation | 1 | 1997 | 1083 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1995 | 1539 | 0.010 |
Why?
|
Keratitis | 1 | 1994 | 239 | 0.010 |
Why?
|
Chronic Disease | 2 | 1997 | 9266 | 0.010 |
Why?
|
Laser Therapy | 1 | 1997 | 1089 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1992 | 15638 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1993 | 791 | 0.010 |
Why?
|
Rabbits | 1 | 1994 | 4771 | 0.000 |
Why?
|
Fibrosis | 1 | 1995 | 2038 | 0.000 |
Why?
|
Forecasting | 1 | 1995 | 2920 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1995 | 13447 | 0.000 |
Why?
|
Surgical Procedures, Operative | 1 | 1995 | 1911 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1995 | 5098 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17617 | 0.000 |
Why?
|
Kidney | 1 | 1995 | 7016 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9160 | 0.000 |
Why?
|
Databases, Factual | 1 | 1993 | 7980 | 0.000 |
Why?
|
Radiography | 1 | 1987 | 6955 | 0.000 |
Why?
|
Brain | 1 | 1993 | 26951 | 0.000 |
Why?
|